Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Revenue

In the year 2025, Korea Arlico Pharm had annual revenue of 201.20B KRW with 5.65% growth. Korea Arlico Pharm had revenue of 48.33B in the quarter ending December 31, 2025, a decrease of -7.66%.

• Revenue: 201.20B
• Revenue Growth: +5.65%
• P/S Ratio: 0.28
• Revenue / Employee: 1.80B
• Employees: 112
• Market Cap: 56.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	201.20B	10.77B	5.65%
Dec 31, 2024	190.44B	3.28B	1.75%
Dec 31, 2023	187.15B	19.42B	11.58%
Dec 31, 2022	167.74B	27.58B	19.68%
Dec 31, 2021	140.16B	15.35B	12.30%